Pinnacle Financial Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $4.91K | Hold |
55
| – | – | ﹤0.01% | 507 |
|
2024
Q4 | $4.61K | Hold |
55
| – | – | ﹤0.01% | 502 |
|
2024
Q3 | $4.61K | Hold |
55
| – | – | ﹤0.01% | 503 |
|
2024
Q2 | $3.77K | Hold |
55
| – | – | ﹤0.01% | 521 |
|
2024
Q1 | $3.77K | Hold |
55
| – | – | ﹤0.01% | 516 |
|
2023
Q4 | $3.18K | Sell |
55
-4,231
| -99% | -$245K | ﹤0.01% | 512 |
|
2023
Q3 | $226K | Sell |
4,286
-1,069
| -20% | -$56.4K | 0.01% | 368 |
|
2023
Q2 | $290K | Buy |
5,355
+229
| +4% | +$12.4K | 0.01% | 342 |
|
2023
Q1 | $256K | Buy |
5,126
+80
| +2% | +$4K | 0.01% | 354 |
|
2022
Q4 | $233K | Buy |
5,046
+4,991
| +9,075% | +$231K | 0.01% | 354 |
|
2022
Q3 | $2K | Hold |
55
| – | – | ﹤0.01% | 508 |
|
2022
Q2 | $2K | Sell |
55
-4,854
| -99% | -$177K | ﹤0.01% | 423 |
|
2022
Q1 | $217K | Buy |
4,909
+30
| +0.6% | +$1.33K | 0.01% | 349 |
|
2021
Q4 | $207K | Sell |
4,879
-4
| -0.1% | -$170 | 0.01% | 377 |
|
2021
Q3 | $212K | Sell |
4,883
-84
| -2% | -$3.65K | 0.01% | 372 |
|
2021
Q2 | $212K | Sell |
4,967
-830
| -14% | -$35.4K | 0.01% | 352 |
|
2021
Q1 | $224K | Buy |
5,797
+5,686
| +5,123% | +$220K | 0.01% | 328 |
|
2020
Q4 | $4K | Sell |
111
-6,401
| -98% | -$231K | ﹤0.01% | 426 |
|
2020
Q3 | $249K | Hold |
6,512
| – | – | 0.01% | 308 |
|
2020
Q2 | $229K | Sell |
6,512
-173
| -3% | -$6.08K | 0.01% | 300 |
|
2020
Q1 | $219K | Sell |
6,685
-1,233
| -16% | -$40.4K | 0.02% | 304 |
|
2019
Q4 | $358K | Buy |
7,918
+163
| +2% | +$7.37K | 0.02% | 290 |
|
2019
Q3 | $315K | Buy |
+7,755
| New | +$315K | 0.02% | 279 |
|
2019
Q2 | – | Sell |
-111
| Closed | -$4K | – | 363 |
|
2019
Q1 | $4K | Buy |
+111
| New | +$4K | ﹤0.01% | 419 |
|
2018
Q4 | – | Sell |
-111
| Closed | -$4K | – | 331 |
|
2018
Q3 | $4K | Buy |
+111
| New | +$4K | ﹤0.01% | 417 |
|
2017
Q3 | – | Sell |
-1,500
| Closed | -$42K | – | 300 |
|
2017
Q2 | $42K | Buy |
+1,500
| New | +$42K | 0.01% | 353 |
|